Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
25.87
-0.73 (-2.74%)
At close: May 21, 2026
SHE:301089 Market Cap
SHE:301089 has a market cap or net worth of 3.27 billion as of May 21, 2026. Its market cap has decreased by -3.79% in one year.
Market Cap
3.27B
Enterprise Value
3.05B
Revenue
373.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.87
Market Cap Chart
Since October 27, 2021, SHE:301089's market cap has decreased from 3.63B to 3.27B, a decrease of -9.85%. That is a compound annual growth rate of -2.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 3.27B | -7.61% |
| Dec 31, 2025 | 3.54B | -0.67% |
| Dec 31, 2024 | 3.57B | -47.81% |
| Dec 29, 2023 | 6.83B | -24.66% |
| Dec 30, 2022 | 9.07B | -10.45% |
| Dec 31, 2021 | 10.13B | 178.97% |
| Oct 27, 2021 | 3.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 3.58B |
| Huaren Pharmaceutical | 3.56B |
| Hunan Hansen Pharmaceutical | 3.56B |
| Tibet AIM Pharm. | 3.56B |
| Harbin Medisan Pharmaceutical | 3.49B |
| Shanghai MicuRx Pharmaceutical | 3.43B |
| PKU HealthCare Corp.,Ltd. | 3.41B |
| Honz Pharmaceutical | 3.41B |